The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, P., Pataka A., Terzi E., Hohenforst-Schmidt W., Machairiotis N., Huang H., et al. (2013).  Intensive care unit and lung cancer: when should we intubate?. J Thorac Dis. 5 Suppl 4, S407-12.
Zarogoulidis, P., Papanas N., Kouliatsis G., Spyratos D., Zarogoulidis K., & Maltezos E. (2011).  Inhaled insulin: too soon to be forgotten?. J Aerosol Med Pulm Drug Deliv. 24(5), 213-23.
Zarogoulidis, P., Huang H., Yang M., Zhou J., Jiao Y., Wang Q., et al. (2020).  Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?. J Cancer. 11(6), 1606-1613.
Zarogoulidis, P., Glaros D., Kontakiotis T., Froudarakis M., Kioumis I., Kouroumichakis I., et al. (2012).  Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.. Int J Gen Med. 5, 175-82.
Zarogoulidis, P., Papanas N., Kioumis I., Chatzaki E., Maltezos E., & Zarogoulidis K. (2012).  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.. Eur J Clin Pharmacol. 68(5), 479-503.
Zarogoulidis, P., Chinelis P., Efthymiou C., Athanasiadou A., Mpikos V., Papatsibas G., et al. (2017).  EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.. Respir Med Case Rep. 22, 7-10.
Zarogoulidis, P., Tsakiridis K., Kioumis I., & Zarogoulidis K. (2014).  Cardiothoracic diseases: basic treatment.. J Thorac Dis. 6 Suppl 1, S1.
Zarogoulidis, K., Mylonaki E., Kakavelas P., Zarogoulidis P., Tsiouda T., Rapti E., et al. (2009).  Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.. Lung Cancer. 66(2), 226-30.
Zarogoulidis, P., Tsakiridis K., & Zarogoulidis K. (2013).  Lung cancer: an update on current and future diagnostic and treatment techniques.. J Thorac Dis. 5 Suppl 4, S341.
Zarogoulidis, P., Tryfon S., Sapalidis K., Tsakiridis K., Baka S., Huang H., et al. (2020).  Bronchial HPV; the good the bad and the unknown.. Respir Med Case Rep. 30, 101053.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sahpatzidou D., Freitag L., Sakkas L., et al. (2014).  A gene therapy induced emphysema model and the protective role of stem cells.. Diagn Pathol. 9, 195.
Zarogoulidis, P., Darwiche K., Yarmus L., Spyratos D., Secen N., Hohenforst-Schmidt W., et al. (2014).  Defense mechanisms of the respiratory system and aerosol production systems.. Med Chem. 10(2), 123-36.
Zarogoulidis, P., Huang H., Bai C., Kosmidis C., Porpodis K., Kallianos A., et al. (2018).  A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking.. Respir Med Case Rep. 23, 38-42.
Zarogoulidis, P., Darwiche K., Hohenforst-Schmidt W., Huang H., Li Q., Freitag L., et al. (2013).  Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.. Future Oncol. 9(8), 1171-94.
Zarogoulidis, P., Lampaki S., Yarmus L., Kioumis I., Pitsiou G., Katsikogiannis N., et al. (2014).  Interleukin-7 and interleukin-15 for cancer.. J Cancer. 5(9), 765-73.
Zarogoulidis, P., Athanasiou E., Tsiouda T., Hatzibougias D., Huang H., Bai C., et al. (2017).  Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.. Respir Med Case Rep. 22, 197-202.
Zarogoulidis, P., Sapalidis K., Fyntanidou V., Kosmidis C., Amaniti A., Koulouris C., et al. (2019).  Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy. Expert Review of Respiratory Medicine. 1375(121), 1153 - 1159.
Zarogoulidis, P., Cheva A., Zarampouka K., Huang H., Li C., Huang Y., et al. (2013).  Tocopherols and tocotrienols as anticancer treatment for lung cancer: future nutrition.. J Thorac Dis. 5(3), 349-52.
Zarogoulidis, P., Glaros D., Kioumis I., Terzi E., Porpodis K., Tsiotsios A., et al. (2012).  Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010.. Int J Gen Med. 5, 675-82.
Zarogoulidis, P., Kontakiotis T., Tsakiridis K., Karanikas M., Simoglou C., Porpodis K., et al. (2012).  Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review.. Ther Clin Risk Manag. 8, 279-86.
Zarogoulidis, P., Yarmus L., Darwiche K., Walter R., Huang H., Li Z., et al. (2013).  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.. Immunome Res. 9(62), 16535.
Zarogoulidis, P., Lampaki S., J Turner F., Huang H., Kakolyris S., Syrigos K., et al. (2014).  mTOR pathway: A current, up-to-date mini-review (Review).. Oncol Lett. 8(6), 2367-2370.
Zarogoulidis, P., Kontakiotis T., & Zarogoulidis K. (2012).  Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".. Ther Deliv. 3(8), 919-21.
Zarogoulidis, P., Kioumis I., Pitsiou G., Porpodis K., Lampaki S., Papaiwannou A., et al. (2014).  Pneumothorax: from definition to diagnosis and treatment.. J Thorac Dis. 6(Suppl 4), S372-6.
Zarogoulidis, K., Porpodis K., Domvri K., Eleftheriadou E., Ioannidou D., & Zarogoulidis P. (2016).  Diagnosing and treating pancoast tumors.. Expert Rev Respir Med. 10(12), 1255-1258.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.